18
April 2024 Apr 2024
Posted April 18, 2024
The ALIGNED study may help your patients with depression find the right antidepressant medication.
The George Institute for Global Health, St Vincent’s Hospital Sydney, and collaborating institutions across Australia are seeking participants for a new study looking at whether tailored antidepressant therapy based on individual patient’s genetic makeup can improve remission rates in depressed patients initiating antidepressants by reducing trial-and-error iterations, and better managing side effects.
The ALIGNED study is an investigator-initiated, double-blind randomised-controlled trial of pharmacogenomics-guided therapy versus standard care for people with depression. The study is funded by the Medical Research Future Fund.
For all participants enrolled in the study, the prescribing clinician will be provided with an individualised treatment guide containing antidepressant recommendations to inform choice/dosing of antidepressant therapy for your patient.
Click here to find out more about the study. GP Practice flyer. Introductory letter.
Subscribe to our mailing list to get all the latest news updates delivered to your inbox.
Hunter Medical Research Institute in partnership with Hunter New England Local Health District, The University of Newcastle and Mercy Services aim to evaluate the effect of implementation of the ESTEEM Program with NGOs providing community based care in regional areas.
The purpose of this research project is to explore your thoughts and perspectives on healthy ageing in relation to your current understanding of dementia, including knowledge, attitudes, and modifiable risk factors.
This research aims to identify and explore the knowledge, attitudes, and practices of young people (16-24 years) in relation to their knowledge, access, and usage of PrEP, along with the attitudes and experience of Healthcare and service providers who provide and recommend PrEP to young people in Australia.